CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $880,858 | -84.0% | 32,331 | -86.9% | 0.00% | -85.7% |
| Q2 2023 | $5,504,005 | -22.2% | 247,371 | -24.3% | 0.01% | -22.2% |
| Q1 2023 | $7,076,170 | +200.0% | 326,693 | +181.3% | 0.01% | +200.0% |
| Q4 2022 | $2,358,641 | -20.2% | 116,132 | +0.7% | 0.00% | -25.0% |
| Q3 2022 | $2,957,343 | -47.7% | 115,341 | -51.5% | 0.00% | -71.4% |
| Q2 2022 | $5,656,000 | +592.3% | 237,861 | +555.6% | 0.01% | +600.0% |
| Q1 2022 | $817,000 | +10.0% | 36,279 | -3.3% | 0.00% | +100.0% |
| Q4 2021 | $743,000 | -1.6% | 37,536 | -2.2% | 0.00% | -50.0% |
| Q3 2021 | $755,000 | -13.1% | 38,368 | -2.9% | 0.00% | 0.0% |
| Q2 2021 | $869,000 | -29.1% | 39,502 | -23.3% | 0.00% | 0.0% |
| Q1 2021 | $1,225,000 | -11.7% | 51,505 | -2.8% | 0.00% | -33.3% |
| Q4 2020 | $1,387,000 | +43.7% | 53,014 | -4.4% | 0.00% | +50.0% |
| Q3 2020 | $965,000 | +2.7% | 55,426 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $940,000 | +12.3% | 55,876 | -20.7% | 0.00% | 0.0% |
| Q1 2020 | $837,000 | 0.0% | 70,421 | +1.8% | 0.00% | 0.0% |
| Q4 2019 | $837,000 | -4.7% | 69,146 | +11.4% | 0.00% | 0.0% |
| Q3 2019 | $878,000 | +26.5% | 62,087 | -0.3% | 0.00% | +100.0% |
| Q2 2019 | $694,000 | -7.0% | 62,279 | -2.0% | 0.00% | -50.0% |
| Q1 2019 | $746,000 | -14.6% | 63,568 | -2.8% | 0.00% | 0.0% |
| Q4 2018 | $874,000 | -13.2% | 65,400 | -8.9% | 0.00% | 0.0% |
| Q3 2018 | $1,007,000 | -10.8% | 71,801 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,129,000 | -6.1% | 71,801 | -1.8% | 0.00% | -33.3% |
| Q1 2018 | $1,202,000 | -10.7% | 73,083 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $1,346,000 | +67.6% | 74,549 | +79.2% | 0.00% | +50.0% |
| Q3 2017 | $803,000 | +63.5% | 41,598 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $491,000 | +57.4% | 41,598 | +46.2% | 0.00% | 0.0% |
| Q1 2017 | $312,000 | +50.7% | 28,453 | 0.0% | 0.00% | – |
| Q4 2016 | $207,000 | +11.9% | 28,453 | 0.0% | 0.00% | – |
| Q3 2016 | $185,000 | +19.4% | 28,453 | 0.0% | 0.00% | – |
| Q2 2016 | $155,000 | +16.5% | 28,453 | 0.0% | 0.00% | – |
| Q1 2016 | $133,000 | -6.3% | 28,453 | 0.0% | 0.00% | – |
| Q4 2015 | $142,000 | +32.7% | 28,453 | 0.0% | 0.00% | – |
| Q3 2015 | $107,000 | -37.4% | 28,453 | 0.0% | 0.00% | – |
| Q2 2015 | $171,000 | – | 28,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |